CHPT Targeting Special-purpose PCBs

Reading time ( words)

IC testing solution provider Chunghwa Precision Test Technology (CHPT) plans to invest an estimated NT$1.05 billion ($34.9 million) to develop new solutions for the manufacture of special-purpose PCBs, according to a Digitimes report.

About NT$500 million of the investment will be used for R&D and the establishment of verification-use production lines in the second half of 2017, according to the company. The remaining investment will be realized through 2019.


Suggested Items

HDI’s Beneficial Influence on High-Frequency Signal Integrity

10/17/2017 | Happy Holden, I-Connect007
The increasingly widespread use of finepitch ball-grid array (BGA), chip scale packaging (CSP), and other evolving technology form-factors means that new fabrication techniques must be used to create printed circuit boards (PCBs).

Embedding Active and Passive Components in Organic PCBs for More Reliability and Miniaturization

06/20/2017 | Thomas Hofmann, HOFMANN LEITERPLATTEN GMBH
Hofmann Leiterplatten GmbH has developed a wide range of products in the last 25 years. New manufacturing know-how has been developed in fabricating organic PCB with embedded devices. A special name, AML (active multilayer), was created to differentiate the surface mount devices (SMD) and the device embedded technology (DET) PCBs. Manufacturing processes that are not typical for standard PCB fabrication shops has been developed.

EIPC Workshop on PCB BioMEMS

03/28/2017 | Alun Morgan, European Institute of Printed Circuits
The Premier Inn conference centre at Heathrow Airport was the venue for the EIPC workshop on PCB BioMEMS. What, I hear you ask, is a PCB BioMEMS? This is an abbreviation for biomedical (or biological) microelectromechanical systems, otherwise known as lab-on-chip.

Copyright © 2018 I-Connect007. All rights reserved.